Ethical approval on Neuren Pharmaceuticals’ Angelman drug study.

- Advertisement -

Neuren Pharmaceuticals (NEU) has received ethics approval to proceed with the phase two clinical study of a treatment for Angelman syndrome in Australia. Angelman syndrome is defined by significant developmental delay and learning difficulties, which manifest as….Read More

Hot this week

Is Ontario’s Fiscal Outlook Worsening? A Closer Look at the 2026 Budget Deficit Surge

The province had tabled a CAD 244 billion spending...

Tonga Faces Dengue Outbreak and Climate Concerns as Authorities Step Up Response Efforts

Recent reports from Matangi, Tonga, indicate that Tonga is...

Myanmar Reduces Aung San Suu Kyi’s Sentence Amid Wider Prisoner Amnesty and Global Concerns

The government of Myanmar, which is led by the...

Durban Domination: South Africa Women Punish India’s Collapse to Seize 2-0 Series Control

On Sunday, April 19, 2026, in the second T20I...

A New Phase in UK–EU Relations? Energy Cooperation and Erasmus+ Deal Explained

On Monday, 30 March ’26, the council formally authorised...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories